Goodhome
Karl Nislow is the Founder and CEO of Goodhome, a company reimagining how we protect our health by starting where we live. Goodhome makes it easy to detect and reduce environmental toxin exposure through science-backed home testing, fast turnaround, and clear, actionable insights.
Previously, Karl served as a fractional executive and advisor to health and wellness startups across consumer goods, technology, and biotech. He helped bring the first consumer precision phage product to market at Parallel Health (TechCrunch Disrupt 2023 Finalist) and played a key role in scaling early brands at the intersection of preventative health and longevity science.
He’s also been an active voice in the longevity and biohacker communities, including as an early member of Bryan Johnson’s Blueprint. His work blends a deep belief in preventative care with a strategic lens on what it takes to build trust and traction in consumer health.
This person is not in any teams
This person is not in any offices